Cargando…
Factors associated with prescription drug monitoring program utilisation: a cross-sectional survey of community pharmacists
BACKGROUND: Prescription drug monitoring programs (PDMP) are databases which collect prescribing and dispensing information for high-risk medicines, and are one approach to mitigate prescription opioid-related risks. AIM: To examine correlates of PDMP use under voluntary and mandatory conditions, am...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759276/ https://www.ncbi.nlm.nih.gov/pubmed/36528707 http://dx.doi.org/10.1007/s11096-022-01523-3 |
_version_ | 1784852196522721280 |
---|---|
author | Picco, Louisa Lam, Tina Xia, Ting Nielsen, Suzanne |
author_facet | Picco, Louisa Lam, Tina Xia, Ting Nielsen, Suzanne |
author_sort | Picco, Louisa |
collection | PubMed |
description | BACKGROUND: Prescription drug monitoring programs (PDMP) are databases which collect prescribing and dispensing information for high-risk medicines, and are one approach to mitigate prescription opioid-related risks. AIM: To examine correlates of PDMP use under voluntary and mandatory conditions, among a representative sample of community pharmacists in Victoria, Australia. METHOD: An online anonymous survey was conducted and collected data in relation to pharmacist and pharmacy characteristics, comfort in performing certain tasks, PDMP training and the frequency of PDMP use under voluntary and mandatory conditions. Multivariate logistic regression models were performed to determine the effect of each covariate on voluntary and mandatory PDMP use. RESULTS: In total, 265 pharmacists participated (response rate 47%). Under voluntary conditions, a quarter of pharmacists (24.9%) used the PDMP all the time, while half (51.7%) used the PDMP all of the time, once mandated. Pharmacies that stocked naloxone (OR: 1.96; 95% CI 1.11–3.45) and pharmacists that had attended formal PDMP training (OR: 1.78; 95% CI 1.05–3.05), were significantly associated with regular PDMP use under voluntary conditions. Under mandatory conditions, increased odds of PDMP use were associated with pharmacies that stocked naloxone (OR: 1.88; 95% CI 1.06–3.34). Pharmacists working in regional and rural areas had significantly lower odds (OR: 0.35; 95% CI 0.20–0.63) of always using the PDMP, as did pharmacists with > 15 years’ experience (OR: 0.24; 95% CI 0.11–0.51) once use was mandated. CONCLUSION: Given that PDMP utilisation was slower or less regular amongst pharmacists located in regional and rural areas, pharmacists with more years of experience and those not already supplying naloxone, targeted training aimed at these sub-populations may be beneficial. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11096-022-01523-3. |
format | Online Article Text |
id | pubmed-9759276 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-97592762022-12-19 Factors associated with prescription drug monitoring program utilisation: a cross-sectional survey of community pharmacists Picco, Louisa Lam, Tina Xia, Ting Nielsen, Suzanne Int J Clin Pharm Research Article BACKGROUND: Prescription drug monitoring programs (PDMP) are databases which collect prescribing and dispensing information for high-risk medicines, and are one approach to mitigate prescription opioid-related risks. AIM: To examine correlates of PDMP use under voluntary and mandatory conditions, among a representative sample of community pharmacists in Victoria, Australia. METHOD: An online anonymous survey was conducted and collected data in relation to pharmacist and pharmacy characteristics, comfort in performing certain tasks, PDMP training and the frequency of PDMP use under voluntary and mandatory conditions. Multivariate logistic regression models were performed to determine the effect of each covariate on voluntary and mandatory PDMP use. RESULTS: In total, 265 pharmacists participated (response rate 47%). Under voluntary conditions, a quarter of pharmacists (24.9%) used the PDMP all the time, while half (51.7%) used the PDMP all of the time, once mandated. Pharmacies that stocked naloxone (OR: 1.96; 95% CI 1.11–3.45) and pharmacists that had attended formal PDMP training (OR: 1.78; 95% CI 1.05–3.05), were significantly associated with regular PDMP use under voluntary conditions. Under mandatory conditions, increased odds of PDMP use were associated with pharmacies that stocked naloxone (OR: 1.88; 95% CI 1.06–3.34). Pharmacists working in regional and rural areas had significantly lower odds (OR: 0.35; 95% CI 0.20–0.63) of always using the PDMP, as did pharmacists with > 15 years’ experience (OR: 0.24; 95% CI 0.11–0.51) once use was mandated. CONCLUSION: Given that PDMP utilisation was slower or less regular amongst pharmacists located in regional and rural areas, pharmacists with more years of experience and those not already supplying naloxone, targeted training aimed at these sub-populations may be beneficial. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11096-022-01523-3. Springer International Publishing 2022-12-17 2023 /pmc/articles/PMC9759276/ /pubmed/36528707 http://dx.doi.org/10.1007/s11096-022-01523-3 Text en © The Author(s), under exclusive licence to Springer Nature Switzerland AG 2022, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Research Article Picco, Louisa Lam, Tina Xia, Ting Nielsen, Suzanne Factors associated with prescription drug monitoring program utilisation: a cross-sectional survey of community pharmacists |
title | Factors associated with prescription drug monitoring program utilisation: a cross-sectional survey of community pharmacists |
title_full | Factors associated with prescription drug monitoring program utilisation: a cross-sectional survey of community pharmacists |
title_fullStr | Factors associated with prescription drug monitoring program utilisation: a cross-sectional survey of community pharmacists |
title_full_unstemmed | Factors associated with prescription drug monitoring program utilisation: a cross-sectional survey of community pharmacists |
title_short | Factors associated with prescription drug monitoring program utilisation: a cross-sectional survey of community pharmacists |
title_sort | factors associated with prescription drug monitoring program utilisation: a cross-sectional survey of community pharmacists |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759276/ https://www.ncbi.nlm.nih.gov/pubmed/36528707 http://dx.doi.org/10.1007/s11096-022-01523-3 |
work_keys_str_mv | AT piccolouisa factorsassociatedwithprescriptiondrugmonitoringprogramutilisationacrosssectionalsurveyofcommunitypharmacists AT lamtina factorsassociatedwithprescriptiondrugmonitoringprogramutilisationacrosssectionalsurveyofcommunitypharmacists AT xiating factorsassociatedwithprescriptiondrugmonitoringprogramutilisationacrosssectionalsurveyofcommunitypharmacists AT nielsensuzanne factorsassociatedwithprescriptiondrugmonitoringprogramutilisationacrosssectionalsurveyofcommunitypharmacists |